Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant
US12419951B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 31, 2020 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Sep 13, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains to the field of pharmaceutical technology. Specifically, the present invention relates to a zinc risedronate micro/nano adjuvant with sustained-release function formed by mineralization of zinc ions and risedronic acid as main components and its use as a vaccine adjuvant. The present invention also relates to a method for preparing zinc risedronate micro/nano adjuvant. The present invention also relates to a chemical composition, vaccine adjuvant and vaccine composition comprising zinc risedronate micro/nano adjuvant. The present invention also relates to a use of zinc risedronate micro/nano adjuvant as a vaccine adjuvant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.